Alto Neuroscience, Inc. (ANRO) Stock Forecast
ANRO analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 4.82 / 5 from 11 analysts
- Price target
- $38.38 average of analyst targets
- Upside to target
- +74.9% from the latest close
- Next earnings
- November 11, 2026 EPS estimate $-0.60
- 52-week range
- $10.20 – $36.64
ANRO analyst ratings
11 analystsNumber of analysts at each rating.
ANRO price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
ANRO earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.70 | −$0.89 | −$0.60 | −$0.52 | −35.2% | 7 |
| Current fiscal year (FY2026) | −$2.92 | −$3.33 | −$2.61 | — | — | 6 |
| Next fiscal year (FY2027) | −$3.29 | −$4.10 | −$2.23 | −$2.92 | −12.5% | 7 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
ANRO revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0 | $0 | $0 | 0.0% | 9 |
| Current fiscal year (FY2026) | $0 | $0 | $0 | 0.0% | 9 |
| Next fiscal year (FY2027) | $0 | $0 | $0 | 0.0% | 9 |
ANRO EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
ANRO EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.80 | −$0.80 | −$0.70 | −$0.70 | −$0.70 | −12.0% | 3 up · 0 down |
| Current fiscal year (FY2026) | −$3.15 | −$3.15 | −$2.92 | −$2.92 | −$2.92 | −7.1% | 3 up · 0 down |
| Next fiscal year (FY2027) | −$3.43 | −$3.43 | −$3.29 | −$3.29 | −$3.29 | −4.3% | 3 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
ANRO earnings surprises
Reported EPS vs the consensus estimate for the last 11 quarters; ANRO beat in 7 of 11.
What analysts expect from ANRO
11 analysts cover Alto Neuroscience; their consensus rating is strong buy (4.82 on a 1–5 scale, where 5 is a strong buy). The average price target is $38.38, 74.9% above the latest close of $21.94. Analysts expect earnings of −$2.92 per share for FY2026. For FY2027 the average estimate is −$3.29 per share. Alto Neuroscience beat the EPS estimate in 7 of the last 11 quarters.
Related: ANRO income statement, ANRO key metrics, ANRO chart. See the ANRO stock overview for the latest quote and news.
ANRO forecast FAQ
What is Alto Neuroscience's price target?
The average analyst price target for Alto Neuroscience is $38.38, 74.9% above the latest close of $21.94.
Is Alto Neuroscience a buy, hold or sell?
Of 11 analysts covering Alto Neuroscience, 10 rate it a strong buy, 0 a buy, 1 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Alto Neuroscience's EPS forecast?
Analysts forecast −$2.92 per share for FY2026 (range −$3.33 to −$2.61); for FY2027 the estimate is −$3.29.
When does Alto Neuroscience report earnings?
Alto Neuroscience is expected to report results for the quarter ending September 30, 2026 on November 11, 2026 after the market closes; the EPS estimate is $-0.60.
Does Alto Neuroscience usually beat earnings estimates?
Alto Neuroscience reported EPS at or above the analyst estimate in 7 of the last 11 quarters.